New Russian fever medicine passes clinical trial

New medicine goflikitsept, the developed companies JOINT-STOCK COMPANY "R-FARM", passes clinical trial in FGAOU VO PERVY MGMU NAMED AFTER I. M. SECHENOVA MINZDRAVA RUSSIA (SECHENOVSKY UNIVERSITY). It is intended for treatment of adults with family Mediterranean fever, reports a site of companies. Family Mediterranean fever — this hereditary disease for which repeating attacks of fever and peritonitis are characteristic, can arise arthritis, damage of skin. Without treatment development heavy complication which the system AA-amiloidoz causing damage of kidneys and other bodies is called is probable. Clinical trial of the domestic...